Abstract:The aim of this present clinical pilot study is the display of typical perfusion results in patients with solid, non-cystic breast lesions. The lesions were characterized using contrast enhanced ultrasound (CEUS) with (i) time intensity curve analyses (TIC) and (ii) parametric color maps. The 24 asymptomatic patients included were genetically tested for having an elevated risk for breast cancer. At a center of early detection of familial ovary and breast cancer, those patients received annual MRI and grey-scale ultrasound. If lesions remained unclear or appeared even suspicious, those patients also received CEUS. CEUS was performed after intravenous application of sulfur hexafluoride microbubbles. Digital DICOM cine loops were continuously stored for one minute in PACS (picture archiving and communication system). Perfusion images and TIC analyses were calculated off-line with external perfusion software (VueBox). The lesion diameter ranged between 7 and 15 mm (mean 11 ± 3 mm). Five hypoechoic irregular lesions were scars, 6 lesions were benign and 12 lesions were highly suspicious for breast cancer with irregular enhancement at the margins and a partial wash out. In those 12 cases, histopathology confirmed breast cancer. All the suspicious lesions were correctly identified visually. For the perfusion analysis only Peak Enhancement (PE) and Area Under the Curve (AUC) added more information for correctly identifying the lesions. Typical for benign lesions is a prolonged contrast agent enhancement with lower PE and prolonged wash out, while scars are characterized typically by a reduced enhancement in the center. No differences (p = 0.428) were found in PE in the center of benign lesions (64.2 ± 28.9 dB), malignant lesions (88.1 ± 93.6 dB) and a scar (40.0 ± 17.0 dB). No significant differences (p = 0.174) were found for PE values at the margin of benign lesions (96.4 ± 144.9 dB), malignant lesions (54.3 ± 86.2 dB) or scar tissue (203.8 ± 218.9 dB). Significant differences (p < 0.001) were found in PE of the surrounding tissue when comparing benign lesions (33.6 ± 25.2 dB) to malignant lesions (15.7 ± 36.3 dB) and scars (277.2 ± 199.9 dB). No differences (p = 0.821) were found in AUC in the center of benign lesions (391.3 ± 213.7), malignant lesions (314.7 ± 643.9) and a scar (213.1 ± 124.5). No differences (p = 0.601) were found in AUC values of the margin of benign lesions (313.3 ± 372.8), malignant lesions (272.6 ± 566.4) or scar tissue (695.0 ± 360.6). Significant differences (p < 0.01) were found in AUC of the surrounding tissue for benign lesions (151.7 ± 127.8), malignant lesions (177.9 ± 1345.6) and scars (1091 ± 693.3). There were no differences in perfusion evaluation for mean transit time (mTT), rise time (RT) and time to peak (TTP) when comparing the center to the margins and the surrounding tissue. The CEUS perfusion parameters PE and AUC allow a very good assessment of the risk of malignant breast lesions and thus a downgrading of BI-RADS 4 lesions. The use of the external perfusion software (VueBox, Bracco, Milan, Italy) did not lead to any further improvement in the diagnosis of suspicious breast lesions and does appears not to have any additional diagnostic value in breast lesions.

Quantitative analysis of contrast-enhanced ultrasonography of benign and malignant breast tumors

Quantitative Assessment of Blood Perfusion in Thyroid Nodules by Contrast-Enhanced Ultrasonography

The qualitative and quantitative features of contrast-enhanced ultrasound in biomarker expression of breast cancer

Quantitative Parameters of Contrast-Enhanced Ultrasound in Breast Invasive Ductal Carcinoma: the Correlation with Pathological Prognostic Factors.

Quantitative analysis with contrast-enhanced ultrasonography in evaluating perfusion characteristics of outer gland of prostate cancer in patients with negative finding by conventional ultrasound

Quantitative analysis of contrast-enhanced ultrasound in breast lesions

Quantification of dynamic contrast-enhanced ultrasound (CEUS) in non-cystic breast lesions using external perfusion software

Contrast-enhanced ultrasonography of cervical carcinoma: perfusion pattern and relationship with tumour angiogenesis.

Added Value of Contrast-Enhanced Ultrasound to Conventional Ultrasound for Characterization of Indeterminate Soft-Tissue Tumors.

Can different regions of interest influence the diagnosis of benign and malignant breast lesions using quantitative parameters of contrast-enhanced sonography?

Correlation Analysis between Expression Profiles of Molecular Markers and Contrast-Enhanced Ultrasound Parameters in Breast Cancer

Evaluation of Breast Lesions by Contrast Enhanced Ultrasound: Qualitative and Quantitative Analysis.

Quantification of CT perfusion curve shape and it's diagnosis of breast cancer: Computer simulation and breast perfusion

Value of Relative Contrast-Enhanced Ultrasound Parameters in Differential Diagnosis of Primary Benign and Malignant Pancreatic Lesions

Clinical value and application of contrast-enhanced ultrasound in the differential diagnosis of malignant and benign breast lesions

Quantitative Analysis of the Time–Intensity Curve of Contrast-Enhanced Ultrasound of the Liver: Differentiation of Benign and Malignant Liver Lesions

Evaluation of the Blood Perfusion Modes in Retroperitoneal Benign and Malignant Masses by Real-Time Contrast-Enhanced Ultrasonograpby

Quantitative analysis of contrast-enhanced ultrasonography on hepatocellular carcinoma: Correlation with tumor differentiated grades

Perfusion Imaging of Ovarian Masses with Contrast-enhanced Ultrasonography

Quantitative Analysis of Contrast-Enhanced Ultrasound in Renal Lesions: a Preliminary Study

The Role of Quantitative Analysis of Contrast-Enhanced Ultrasound Combined with Tumor Marker in the Diagnosis of Peripheral Pulmonary Lesions